TCL Archive “Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million December 6, 1974
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004